Zhang, X., Shao, F., Zhu, L., Ze, Y., Zhu, D., & Bi, Y. (2018). Cardiovascular and microvascular outcomes of glucagon-like peptide-1 receptor agonists in type 2 diabetes: A meta-analysis of randomized controlled cardiovascular outcome trials with trial sequential analysis. BMC Pharmacol Toxicol.
Dyfyniad Arddull ChicagoZhang, Xiaowen, Fei Shao, Lin Zhu, Yuyang Ze, Dalong Zhu, and Yan Bi. "Cardiovascular and Microvascular Outcomes of Glucagon-like Peptide-1 Receptor Agonists in Type 2 Diabetes: A Meta-analysis of Randomized Controlled Cardiovascular Outcome Trials With Trial Sequential Analysis." BMC Pharmacol Toxicol 2018.
Dyfyniad MLAZhang, Xiaowen, et al. "Cardiovascular and Microvascular Outcomes of Glucagon-like Peptide-1 Receptor Agonists in Type 2 Diabetes: A Meta-analysis of Randomized Controlled Cardiovascular Outcome Trials With Trial Sequential Analysis." BMC Pharmacol Toxicol 2018.